Glomerular Neovascularization in Nondiabetic Renal Allograft Is Associated with Calcineurin Inhibitor Toxicity

被引:2
作者
Sawada, Anri [1 ,2 ]
Okumi, Masayoshi [3 ]
Horita, Shigeru [4 ]
Unagami, Kohei [5 ]
Taneda, Sekiko [6 ]
Fuchinoue, Shohei [7 ]
Ishida, Hideki [5 ]
Hattori, Motoshi [8 ]
Tanabe, Kazunari [3 ]
Nitta, Kosaku [9 ]
Koike, Junki [10 ]
Nagashima, Yoji [2 ]
Shimizu, Akira [1 ]
机构
[1] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Dept Surg Pathol, Tokyo, Japan
[3] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[4] Tokyo Womens Med Univ, Kidney Ctr, Div Clin Pathol, Tokyo, Japan
[5] Tokyo Womens Med Univ, Dept Organ Transplant Med, Tokyo, Japan
[6] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan
[7] Tokyo Womens Med Univ, Dept Kidney Surg, Tokyo, Japan
[8] Tokyo Womens Med Univ, Dept Pediat Nephrol, Tokyo, Japan
[9] Tokyo Womens Med Univ, Dept Nephrol, Tokyo, Japan
[10] St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa, Japan
关键词
Glomerular neovascularization; Kidney transplantation; Polar vasculosis; Calcineurin inhibitor; Diabetes mellitus; VASCULAR POLE; REJECTION; PROSPECTS;
D O I
10.1159/000511452
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Extra efferent arterioles, also known as polar vasculosis (PV), are often observed in the glomerular vascular pole and are associated with glomerular hypertrophy, indicating early recurrent diabetic kidney disease (DKD) in renal allografts. However, its significance in patients without diabetes remains uncertain. Methods: A total of 9,004 renal allograft biopsy specimens obtained between January 2007 and December 2017 at Tokyo Women's Medical University were retrospectively analyzed to examine the clinical and pathological significance of PV in renal allografts. PV was identified in 186 biopsy specimens obtained from 165 patients. The PV group comprised 46 patients; 35 patients without DKD and 11 patients with DKD as the initial cause of ESRD, whose clinical information was available and treated with the calcineurin inhibitor (CNI) tacrolimus. The non-PV group comprising patients with renal allografts matched for age and postoperative day included 93 patients without DKD and 16 patients with DKD as the initial cause of ESRD. Results: In patients with nondiabetic renal allografts, systolic blood pressure was significantly higher in the PV group than in the non-PV group. The trough tacrolimus levels during the overall study period and at 2 weeks, 1 month, and 2 years after transplantation were significantly higher in the PV group compared with the non-PV group. Glomerulomegaly was significantly more common. Moreover, ah and aah scores in Banff score were significantly higher in the PV group than in the non-PV group. In those with diabetic renal allografts, although the clinical parameters and tacrolimus trough levels in all time periods were not significantly different between the PV and non-PV groups, the ah score was significantly higher in the PV group. Conclusion: PV was associated with CNI toxicity in nondiabetic but not in diabetic renal allografts. The pathogenesis of PV in renal allografts is considered to be multifactorial.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 20 条
  • [1] [Anonymous], 2007, AM J KIDNEY DIS, V49, pS12
  • [2] Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40
    Basu, Aninda
    Banerjee, Pallavi
    Contreras, Alan G.
    Flynn, Evelyn
    Pal, Soumitro
    [J]. PLOS ONE, 2011, 6 (08):
  • [3] Calcineurin inhibitor toxicity in a renal transplant recipient
    Charney, Douglas A.
    Bhaskaran, Madhu
    Molmenti, Ernesto
    [J]. CLINICAL KIDNEY JOURNAL, 2009, 2 (02): : 175 - 176
  • [4] Endothelial cell transforming growth factor-β receptor activation causes tacrolimus-induced renal arteriolar hyalinosis
    Chiasson, Valorie L.
    Jones, Kathleen A.
    Kopriva, Shelley E.
    Mahajan, Ashutosh
    Young, Kristina J.
    Mitchell, Brett M.
    [J]. KIDNEY INTERNATIONAL, 2012, 82 (08) : 857 - 866
  • [5] Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine
    Falkenhain, ME
    Cosio, FG
    Sedmak, DD
    [J]. TRANSPLANTATION, 1996, 62 (03) : 364 - 370
  • [6] Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes
    Furuichi, Kengo
    Yuzawa, Yukio
    Shimizu, Miho
    Hara, Akinori
    Toyama, Tadashi
    Kitamura, Hiroshi
    Suzuki, Yoshiki
    Sato, Hiroshi
    Uesugi, Noriko
    Ubara, Yoshifumi
    Hisano, Satoshi
    Ueda, Yoshihiko
    Nishi, Shinichi
    Yokoyama, Hitoshi
    Nishino, Tomoya
    Kohagura, Kentaro
    Ogawa, Daisuke
    Mise, Koki
    Shibagaki, Yugo
    Kimura, Kenjiro
    Haneda, Masakazu
    Makino, Hirofumi
    Matsuo, Seiichi
    Wada, Takashi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (01) : 138 - 148
  • [7] The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
    Haas, M.
    Loupy, A.
    Lefaucheur, C.
    Roufosse, C.
    Glotz, D.
    Seron, D.
    Nankivell, B. J.
    Halloran, P. F.
    Colvin, R. B.
    Akalin, Enver
    Alachkar, N.
    Bagnasco, S.
    Bouatou, Y.
    Becker, J. U.
    Cornell, L. D.
    van Huyen, J. P. Duong
    Gibson, I. W.
    Kraus, Edward S.
    Mannon, R. B.
    Naesens, M.
    Nickeleit, V.
    Nickerson, P.
    Segev, D. L.
    Singh, H. K.
    Stegall, M.
    Randhawa, P.
    Racusen, L.
    Solez, K.
    Mengel, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (02) : 293 - 307
  • [8] The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension
    Hoorn, Ewout J.
    Walsh, Stephen B.
    McCormick, James A.
    Fuerstenberg, Antje
    Yang, Chao-Ling
    Roeschel, Tom
    Paliege, Alexander
    Howie, Alexander J.
    Conley, James
    Bachmann, Sebastian
    Unwin, Robert J.
    Ellison, David H.
    [J]. NATURE MEDICINE, 2011, 17 (10) : 1304 - U339
  • [9] A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy
    Hoshino, Junichi
    Furuichi, Kengo
    Yamanouchi, Masayuki
    Mise, Koki
    Sekine, Akinari
    Kawada, Masahiro
    Sumida, Keiichi
    Hiramatsu, Rikako
    Hasegawa, Eiko
    Hayami, Noriko
    Suwabe, Tatsuya
    Sawa, Naoki
    Hara, Shigeko
    Fujii, Takeshi
    Ohashi, Kenichi
    Kitagawa, Kiyoki
    Toyama, Tadashi
    Shimizu, Miho
    Takaichi, Kenmei
    Ubara, Yoshifumi
    Wada, Takashi
    [J]. PLOS ONE, 2018, 13 (02):
  • [10] The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
    Loupy, A.
    Haas, M.
    Solez, K.
    Racusen, L.
    Glotz, D.
    Seron, D.
    Nankivell, B. J.
    Colvin, R. B.
    Afrouzian, M.
    Akalin, E.
    Alachkar, N.
    Bagnasco, S.
    Becker, J. U.
    Cornell, L.
    Drachenberg, C.
    Dragun, D.
    de Kort, H.
    Gibson, I. W.
    Kraus, E. S.
    Lefaucheur, C.
    Legendre, C.
    Liapis, H.
    Muthukumar, T.
    Nickeleit, V.
    Orandi, B.
    Park, W.
    Rabant, M.
    Randhawa, P.
    Reed, E. F.
    Roufosse, C.
    Seshan, S. V.
    Sis, B.
    Singh, H. K.
    Schinstock, C.
    Tambur, A.
    Zeevi, A.
    Mengel, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (01) : 28 - 41